BioOrbit, a British startup, is advancing drug-crystallisation technology by launching a compact unit, Box-E, to the International Space Station aboard a SpaceX flight. This device, roughly the size of a microwave, is designed to grow ultra-pure protein crystals to develop self-injectable cancer drugs. The technology, developed in BioOrbit’s London labs, aims to revolutionize cancer treatment by enabling the production of highly effective medications in space.
Back
